share_log

Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $2

Benzinga Real-time News ·  Aug 17, 2022 07:24

Piper Sandler analyst Do Kim maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price target from $1 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment